Oncology Voice Network (OVN) Podcast

Oncology Voice Network

Oncology Voice Network (OVN) Podcast brings the real-world voices of oncology drug development to life. Hosted by Dr. Kirk Shepard and Dr. Ramin Farhood, the series features candid conversations with leaders and innovators across the oncology ecosystem. Each episode explores real-world experiences, lessons learned, bold ideas, challenges, and best practices and solutions from pharmaceutical executives, academic researchers, patients, patient advocates, and innovation partners—connecting the voices that drive oncology drug development forward. At its core, the show reflects the mission of the Oncology Voice Network: breaking silos, amplifying voices, and fostering cross-functional collaboration across all disciplines to reshape oncology drug development. Whether you’re in pharmaceuticals, biotech, healthcare, or advocacy, this podcast offers insights and connections to help drive progress across the field.

Episodes

  1. May 26

    The Role of Field Medical in Advancing Cancer Treatment

    What does it take to transform scientific discovery into real-world cancer care? Explore the critical, yet often misunderstood, role of field medical professionals in oncology. In this episode of the Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Robin Winter-Sperry, a trailblazer, advocate, and chapter co-author in the Voices of Oncology book. Together, they dive into the evolution of field medical teams, revealing how scientific exchange, mentorship, and communication lead to better patient outcomes. Robin shares her unique journey from clinical practice to industry leadership, explaining how field medical professionals bridge the gap between research and practice, bringing valuable insights from the healthcare community back to pharma and biotech. The conversation covers how collaboration can break down, where critical information can sometimes get lost, and why recognizing and leveraging resident expertise is vital for progress. Discover fresh perspectives on how field medical shapes clinical practice, adapts to rapid technological change, and is poised for an impactful future—especially in an era of AI and patient empowerment.  Listen now and join the movement to elevate every voice in oncology. Follow Us Facebook @OncologyVoiceNetwork LinkedIn @OncologyVoiceNetwork X @OncologyVoiceNetwork Presented by Oncology Voice Network www.oncologyvoicenetwork.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    24 min
  2. Mar 31

    Breakthroughs in Oncology Drug Development with Dr. Roy Baynes

    How do world-changing cancer treatments go from concept to reality?  In this episode of the Oncology Voice Network Podcast, host Dr. Kirk Shepard welcomes Dr. Roy Baynes, the Chief Medical Officer of ICON Therapeutics and the architect behind the clinical strategy for Keytruda (pembrolizumab), one of the most transformative cancer therapies of our time. Listen as Dr. Baynes shares his personal journey from academia to industry, his leadership and collaboration philosophy, and the critical decisions that accelerated one drug to impact millions. He reveals how adaptive trials, bold partnerships, clear strategy, and relentless patient focus set new standards—not only for science, but for access and equity in cancer care. From lessons learned at Amgen, Gilead, and Merck, to navigating regulatory relationships and cross-functional teamwork, this episode is a masterclass in what it takes to drive rapid oncology innovation. Dr. Baynes also looks ahead to the future, sharing his optimism for breakthroughs, actionable insights for teams, and why patient-centered purpose should lead every step. Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now. Follow Us Facebook @OncologyVoiceNetwork LinkedIn @OncologyVoiceNetwork X @OncologyVoiceNetwork Presented by Oncology Voice Network www.oncologyvoicenetwork.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    28 min
  3. Mar 17

    The Power of Commercial Leadership in Oncology

    What does it mean to be the true “voice of commercial” in oncology, and why does it matter more than ever? In this episode of Oncology Voice Network Podcast, join Dr. Kirk Shepard as he welcomes Daniel Switzer, Head of U.S. Oncology at Daiichi Sankyo, for a revealing look inside the commercial engine that drives cancer innovation from the lab all the way to the patient. With two decades of leading launches, transformations, and cross-functional teams, Daniel Switzer shares his most pivotal moments, from high-stakes encounters with patients to standing ovations at ASCO Congress. Discover why commercial is about so much more than sales, how ethical responsibility and clear alignment can truly change outcomes, and what happens when teams get it wrong. Daniel Switzer discusses breaking down silos, building bridges with R&D, and the necessity of early, unified collaboration in launching life-changing therapies. Plus, hear why the Oncology Voice Network and industry-wide learning are the next frontiers in elevating patient care. Whether you're in pharma, research, or just passionate about innovation, this episode will reframe what commercial leadership means in today’s oncology world. Tune in now and get inspired to bridge the gaps that matter most. Follow Us Facebook @OncologyVoiceNetwork LinkedIn @OncologyVoiceNetwork X @OncologyVoiceNetwork Presented by Oncology Voice Network www.oncologyvoicenetwork.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    31 min
  4. Feb 17

    How Cross-Functional Teams Reshape Cancer Care

    How does real innovation in cancer therapy begin? Step into the world of preclinical drug discovery, where every molecule—and every lesson—matters.  In this episode of Oncology Voice Network Podcast, Host Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.  Together, they explore how personal stories, cross-functional teamwork, and the willingness to share both successes and failures can reshape outcomes for cancer patients. Dr. Fine reflects on the human inspiration behind his decades of work, breaks the myth of the lone scientist by emphasizing the power of collaboration, and explains how preclinical data guides every step of a therapy’s path to patients. He also emphasizes the importance of open partnerships among pharma, biotech, payers, and patient advocates. Looking ahead, they discuss big ideas shaping the future, from data sharing and adaptive trials to more patient-centered strategies. Discover why a new era of shared innovation is essential to accelerating breakthroughs and ensuring no patient is left behind. Tune in now. Follow Us Facebook @OncologyVoiceNetworkLinkedIn @OncologyVoiceNetworkX @OncologyVoiceNetworkPresented by Oncology Voice Network  www.oncologyvoicenetwork.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    24 min
  5. Feb 3

    Trust, Transparency & Timelines: Advancing Cancer Care

    What happens when true experts break down walls to speed up cancer cures? In this episode of the Oncology Voice Network Podcast, host Dr. Kirk Shepard welcomes Rebecca Goldstein, VP of Strategy and Communications at OVN and a self-described “oncology lifer.” Dive into a raw, real-world conversation about the often-overlooked role of innovation partners in pushing oncology drug development forward. Rebecca shares her journey from the lab bench to shaping cross-sector collaboration, revealing what sets innovation partners apart from traditional service providers. She and Dr. Shepard explore why transparent and timely communication isn’t just nice-to-have—it’s essential for real progress. They break down the high cost of information silos, why trust is a two-way street, and how the OVN community is opening new doors for experts, manufacturers, and innovators to learn from each other. You’ll gain practical takeaways on building powerful, trust-based relationships that break through bureaucracy and accelerate patient impact, plus a behind-the-scenes look at the making of Voices of Oncology and how competition gave way to collaboration. Ready to see how a new culture of partnership can transform cancer drug development? Tune in and join the conversation. Follow Us Facebook @OncologyVoiceNetworkLinkedIn @OncologyVoiceNetworkX @OncologyVoiceNetworkPresented by Oncology Voice Network  www.oncologyvoicenetwork.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    25 min

About

Oncology Voice Network (OVN) Podcast brings the real-world voices of oncology drug development to life. Hosted by Dr. Kirk Shepard and Dr. Ramin Farhood, the series features candid conversations with leaders and innovators across the oncology ecosystem. Each episode explores real-world experiences, lessons learned, bold ideas, challenges, and best practices and solutions from pharmaceutical executives, academic researchers, patients, patient advocates, and innovation partners—connecting the voices that drive oncology drug development forward. At its core, the show reflects the mission of the Oncology Voice Network: breaking silos, amplifying voices, and fostering cross-functional collaboration across all disciplines to reshape oncology drug development. Whether you’re in pharmaceuticals, biotech, healthcare, or advocacy, this podcast offers insights and connections to help drive progress across the field.